TP53 mutation in ovarian carcinoma

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1281-1283

  Murphy, M ^a   McManus, D T ^a   Toner, P G ^a   Russell, S E H ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Mutations; Ovarian carcinoma; p53

Indexed keywords

DNA; FLUORESCENT DYE; PARAFFIN; PROTEIN P53;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EMBEDDING; GENE MUTATION; HUMAN; HUMAN TISSUE; METASTASIS; MISSENSE MUTATION; OMENTUM; OVARY CARCINOMA; PRIORITY JOURNAL; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; MUTATION; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING;

EID: 0030852219     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00108-1     Document Type: Article

References (17)

1. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991, 25, 49-53.
2. Levine AJ, Momand J, Finley CA. The p53 tumour suppressor gene. Nature 1991, 351, 453-456.
3. Milner BJ, Allan LA, Eccles DM, et al. p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res 1993, 53, 2128-2132.
4. Kihana, Tsuda H, Teshima S, Okada S, Matsuura S, Hirohashi S. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumour DNA aneuploidy. Jpn J Cancer Res 1992, 83, 978-9846.
5. Okamoto A, Sameshima Y, Yokoyama S, et al. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res 1991, 51, 5171-5176.
6. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C. p53 mutations in ovarian cancer: a late event? Oncogene 1991, 6, 1685-1690.
7. Niwa K, Itoh M, Murase T, Morishita S, Itoh N, Mori H, Tamaya T. Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and pognostic significance. Br J Cancer 1994, 70, 1191-1197.
8. McManus DT, Yap EPH, Maxwell P, Russell SEH, Toner PG, McGee J O'D. p53 expression, mutation and allelic deletion in ovarian cancer. J Pathol 1994, 174(3), 159-168.
9. McManus DT, Murphy M, Arthur K, Hamilton PW, Russell SEH, Toner PG. p53 mutation, allele loss on chromosome17p and DNA content in ovarian carcinoma. J Pathol 1996, 179, 177-182.
10. Sarkar FH, Li YW, Crissman JD. A method for PCR sequencing of the p53 gene from a single 10 μm frozen or paraffin embedded tissue section. Biotechniques 1993, 15, 36-370.
11. Kiyokawa T. Alteration of p53 in ovarian cancer: its occurrence and maintenance in tumour progression. Int J Gynaecol Pathol 1994, 13, 311-318.
12. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 1994, 172, 1-4.
13. Jacobs IJ, Kohler MF, Wiseman RW, et al. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation and X chromosome inactivation. J Natl Cancer Inst 1992, 84, 1793-1798.
14. Mok CH, Tsao SW, Knapp RC, Fishbaugh PM, Lau CC. Unifocal origin of advanced human epithelial ovarian carcinomas. Cancer Res 1992, 52, 5119-5122.
15. Kohler MF, Marks JR, Wiseman RW, et al. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian carcinoma. J Natl Cancer Inst 1993a, 85, 1513-1519.
16. Kupryjanczyk J, Thor AD, Beauchamp R, et al. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 1993, 90, 4961-4965.
17. Kohler MF, Billie-Jo M, Kerns BA, et al. Mutation and over expression of p53 in early stage epithelial ovarian cancer. Obstet Gynaecol 1993b, 81, 643-650.